By integrative m6A sequencing, RNA sequencing, ribosome profiling, RNA immunoprecipitation sequencing, and proteomics, our team has recently identified a novel oncogenic epitranscriptome axis of METTL3-m6A-GLUT1-mTORC1 [75] and YTHDF1-m6A-ARHGEF2 [79] in promoting CRC tumorigenesis. The gene discussed is SLC2A1; the disease is colorectal carcinoma.